Fairmount Funds Management LLC - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (SYRE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 29, 2023, Fairmount Funds Management LLC's relationship to Spyre Therapeutics, Inc. (SYRE) is Director,TenPercentOwner, and currently has 406,038 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRE insiders.
Data Source: SEC.
Fairmount Funds Management LLC - Insider Non-Derivative Transactions at SYRE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 30, 2023 | J -- (Common Stock) | 3435480 | 0 | 0 |
| Dec 30, 2023 | J -- (Common Stock) | 406038 | 0 | 406038 |